Cellular therapy for ocular degeneration
US9074189B2 · kind B2 · utility
0Cited by
74References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 2, 2006 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Nov 14, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2035/124
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods applicable to cell-based or regenerative therapy for ophthalmic diseases and disorders comprising mesenchymal stem cells, particularly those characterized by the expression of at least one of the following surface markers: CD29, CD44, CD105 or CD166, and the lack of expression of at least one of CD14, CD34 or CD45.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.